COGNITION THERAPEUTICS INC (CGTX)
D
Pipeline Grade
Financial Position (from SEC Filings)
$31.2M
Cash & Equivalents
$5.5M
Quarterly Burn Rate
17 mo
Est. Cash Runway
$98M
Market Cap
Estimated from most recent SEC quarterly filing. View SEC filings
Drug Pipeline (0 Assets)
No drugs indexed yet. Pipeline data is populated from ClinicalTrials.gov and openFDA.
Upcoming Catalysts
No upcoming catalysts detected for this company.
Active Clinical Trials (1)
| NCT # | Title | Phase | Status | Enrollment |
|---|---|---|---|---|
| NCT07523048 | Dextromethorphan-Bupropion on Striatal Activity in Adults With Major Depressive Disorder | PHASE2 | Recruiting | 30 |
Source: ClinicalTrials.gov. Trial status last updated by sponsor — may not reflect current state.